Stocks · Health care · Pharmaceutical Preparations

Harmony Biosciences Holdings, Inc.

HRMY Clue Score72
United States Fiscal year ends December CIK 0001802665 Results filed 4 Nov 2026

What the insiders did No buying or selling

By person

7 insiders · 0 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Sandip Kapadia
Chief Financial Officer
—
—
—
24,521
$1.06M
−50.5%
Kumar Budur
Chief Medical Officer
—
—
—
13,115
$564.66K
+1,205%
Jeffrey M. Dayno
President, CEO
—
—
—
7,346
$316.28K
—
Adam H. Zaeske
Chief Commercial Officer
—
—
—
4,327
$186.30K
—
Andrew Serafin
Chief Strategy Officer
—
—
—
1,474
$63.46K
—
Valor IV Pharma Holdings, LLC entity
10% owner
—
—
—
0
$0.00
−100.0%
Jeffrey Dierks
Chief Commercial Officer
—
—
—
0
$0.00
—

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.